Atlas Trials

A Study of Danavorexton (TAK-925) in Adults With Obstructive Sleep Apnea

Clinical trial NCT05180890 · COMPLETED

Trial details

NCT number
NCT05180890
Sponsor
Takeda
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Sleep Apnea
Start date
2022-03-10
Primary completion
2022-11-23
Enrollment
13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.